(NasdaqGM:CLMB), EATONTOWN, N.J., April 01, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) today announced a new partnership with Darktrace, a global leader in AI for cybersecurity. Under this agreement, Climb Channel Solutions will now distribute Darktrace's portfolio of AI-powered […]

(NASDAQ:LTRX), IRVINE, Calif., April 01, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced the appointment of Todd Rychecky as general manager and head of its Out-of-Band (OOB) Management Business Line. With a proven track record in network resilience, SaaS

(NYSE:RNST), TUPELO, Miss., April 01, 2025 (GLOBE NEWSWIRE) — Renasant Corporation (NYSE: RNST) (“Renasant” or “the Company”) announced today that it has completed its merger with The First Bancshares, Inc., the parent company of The First Bank (“The First”), effective April 1, 2025. Although the merger has been completed, full conversion and integration of The

(NasdaqGM:RNAC), FREDERICK, Md., April 01, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases, today announced that its management expects to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 2:15 p.m.

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) — The Canadian Public Accountability Board (CPAB), Canada's public company audit regulator, today released its 2024 annual report. The report covers CPAB's 2024 regulatory assessments and provides updates on strategic initiatives. CPAB's 2024 inspections results indicate an overall decrease in the aggregate findings rate, primarily driven by less significant

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) — CGS Immersive(TM), the leader in enterprise learning that is modernizing training and development with AI and XR technologies, today released its 2025 Operational Excellence Report. The report highlights how AI, immersive tech, and human-AI collaboration are essential to operational excellence and are priorities on the roadmaps of

(NASDAQ:UNCY), LOS ALTOS, Calif., April 01, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will present at the 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, at 2:15 p.m. ET. A link

(NasdaqGM:ULBI), Acquisition of Electrochem Completed and Integration Has Commenced NEWARK, N.Y., April 01, 2025 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows: Fourth Quarter: Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7%

(TSX:MARI),(OTC US:MARIF),(Other OTC:MARIF),(AUST:MC2.AX), VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca” or the “Company”) (TSX: MARI) (ASX: MC2) is pleased to announce that the Company has been admitted to the official list of the Australian Securities Exchange (“ASX“) as a Foreign Exempt Listing, on March 31st 2025 (AEDT), and that

Newly Appointed Board Chair, Philip Astley-Sparke, Brings Transatlantic Late-Stage Development, Regulatory and Commercial Expertise Strengthened Leadership and Expanded U.S. Presence Positions SynOx for Regulatory Filings and Commercialization of Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) DUBLIN, Ireland and OXFORD, United Kingdom, April 01, 2025 (GLOBE NEWSWIRE) — SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical